Fabino Life Sciences's Total Assets for the quarter that ended in Mar. 2024 was ₹153.6 Mil.
During the past 12 months, Fabino Life Sciences's average Total Assets Growth Rate was 220.80% per year.
During the past 3 years, the average Total Assets Growth Rate was 91.30% per year.
During the past 5 years, the average Total Assets Growth Rate was 14.00% per year.
During the past 6 years, Fabino Life Sciences's highest 3-Year average Total Assets Growth Rate was 91.30%. The lowest was -21.80%. And the median was 11.70%.
The historical data trend for Fabino Life Sciences's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Fabino Life Sciences's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Life Sciences (BOM:543444) Total Assets Explanation
Note:
The Net Income data used here is two times the semi-annual (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Fabino Life Sciences's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Fabino Life Sciences Total Assets Related Terms
Thank you for viewing the detailed overview of Fabino Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Fabino Life Sciences (BOM:543444) Business Description
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543444 has been successfully added to your